# Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer

> **NCT06757621** · PHASE3 · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 3142 (estimated)

## Conditions studied

- Breast Carcinoma

## Interventions

- **RADIATION:** Regional Nodal Irradiation

## Key facts

- **NCT ID:** NCT06757621
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-10
- **Primary completion:** 2029-11-01
- **Final completion:** 2032-11-01
- **Target enrollment:** 3142 (ESTIMATED)
- **Last updated:** 2025-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06757621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06757621, "Hypofractionated Postoperative Regional Nodal Irradiation for Patients With Intermediate-risk Breast Cancer". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06757621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*